Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Induction Chemotherapy
  • Leukemia, Myeloid, Acute

abstract

  • Induction treatment with A + C did not improve the CR rate compared with D + C in patients with sAML.

publication date

  • March 20, 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2014.57.0952

PubMed ID

  • 25732165

Additional Document Info

start page

  • 1252

end page

  • 7

volume

  • 33

number

  • 11